China Digest: CertiK, Westlake Therapeutics in funding news

US-headquartered blockchain security player CertiK with significant operations in China raised $37 million in its Series B round. In a separate development, Westlake Therapeutics has bagged 100 million yuan ($15 million) in a new round. 

CertiK bags $37m in Series B 

US-headquartered blockchain security player CertiK with significant operations in China raised $37 million in its Series B round, per a company statement on Thursday. 

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter